Main > HEMATOLOGY > IT. C. Transfusional Fe Overload>



IT. C. Transfusional Fe Overload>'s subsections
(*) BR Approval Date: 2021. 09.13.
(*) USA Approval Date: 2021. 05.01.
>Due to SCD>Treat.>Fe Chelator Tab.
Company
Generic Name: Deferiprone
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2021. 05.25.
RTM
RTM Web-Site

IT. C. Transfusional Fe Overload>'s products
This section has no products